Search

everythinglearnresearchcommunity

for

Search:↓

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

Combination therapy, especially with finasteride, is effective for treating frontal fibrosing alopecia.

5α-reductase inhibitors like finasteride and dutasteride effectively treat BPH by reducing DHT levels.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Using 5 alpha reductase inhibitors may increase dementia risk in the first two years.

Finasteride and dutasteride are effective for long-term treatment of enlarged prostates but have sexual side effects and a risk of high-grade prostate cancer.

Sleep, testosterone levels, and a specific enzyme activity affect skin oil production in women.

Tamsulosin with Serenoa repens is as effective as with 5-alpha-reductase inhibitors but causes fewer side effects.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Dutasteride can stabilize hair loss in patients with frontal fibrosing alopecia, but its safety in women is unclear, so use it with caution.

Men taking 5-alpha reductase inhibitors for prostate issues may be less likely to experience severe COVID-19, but it doesn't prevent ICU admission or death.

Using single dermal papillae is unreliable for analyzing androgen metabolism in hair follicles.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Medications for hair loss and prostate issues can significantly increase the risk of sexual side effects and other negative symptoms.

The authors suggest that 5-α-reductase inhibitors, like dutasteride, are effective in treating frontal fibrosing alopecia and should be the first-line treatment, with other options for severe cases. They also recommend further research on Janus kinase inhibitors.

5-alpha reductase inhibitors can cause sexual, neurologic, endocrine, and cardiovascular side effects, but these are rare and usually stop after ending treatment.

Dutasteride is cheaper than finasteride for treating benign prostatic hyperplasia.

Polygenic risk scores can predict the risk and outcomes of benign prostatic hyperplasia.

A 36-year-old person with a female appearance but male chromosomes was diagnosed with a rare enzyme deficiency affecting sexual development.

More research needed to confirm finasteride as standard treatment for FFA.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Finasteride can cause lasting sexual and mood issues even after stopping the drug.

Herbal drugs show promise for treating alopecia with fewer side effects, but standardization is challenging.

Finasteride and dutasteride can improve hair loss in women, but more research is needed.

Using 5α-reductase inhibitors for hair loss in women doesn't increase cancer risk.

Finasteride temporarily suppresses brain activity, but some effects last even after stopping.

5-alpha reductase inhibitors may help protect the brain and gut in Parkinson's disease.

Finasteride and dutasteride do not significantly change beard thickness in men.